Regeneron Pharmaceuticals | REGN

Stock Price
732.16
Daily Change
0.49%
Yearly
11.12%
Q2 Forecast
704.17
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Kyowa Hakko Kirin 2,680.00 23.00 0.87% -3.98%
Astellas Pharma 2,207.50 -56.50 -2.50% 4.97%
AbbVie 138.01 1.57 1.15% -5.49%
Agenus 1.50 0.04 2.40% -6.56%
Agios Pharmaceuticals 25.35 0.03 0.12% 32.79%
Alimera Sciences 2.76 0.12 4.35% -53.30%
Alnylam Pharmaceuticals 185.26 -1.21 -0.65% 50.55%
Amgen 221.15 2.62 1.20% -12.73%
AstraZeneca 11,660.00 162.00 1.41% 11.66%
Biogen 296.64 -2.05 -0.69% 48.32%
Bluebird Bio 3.33 0.02 0.60% 12.12%
BioMarin Pharmaceutical 86.79 -0.43 -0.49% 16.70%
Bristol-Myers Squibb 64.34 0.63 0.99% -14.17%
Esperion Therapeutics 1.34 -0.06 -4.29% -75.28%
Gilead Sciences 76.84 0.51 0.67% 18.64%
GlaxoSmithKline 1,346.40 -24.60 -1.79% -21.16%
Intercept Pharmaceuticals 10.73 -0.04 -0.37% -39.85%
Incyte Corp 62.03 0.16 0.26% -17.27%
Ionis Pharmaceuticals 40.50 -0.05 -0.12% 12.78%
J&J 154.64 0.27 0.17% -12.98%
Eli Lilly 428.44 1.20 0.28% 37.73%
Merck & Co 110.62 1.45 1.33% 21.37%
Moderna 128.04 -0.86 -0.66% -10.71%
Neurocrine Biosciences 89.84 -0.27 -0.30% -3.14%
Novartis 87.16 0.14 0.16% 1.14%
Novartis 95.77 -0.79 -0.81% 6.83%
Iveric bio Inc. 37.79 0.07 0.17% 265.78%
Opthea 0.59 -0.03 -4.84% -54.62%
Puma Biotechnology 3.36 0.09 2.75% 79.68%
Pfizer 37.88 0.87 2.35% -27.67%
Ultragenyx Pharmaceutical 49.05 0.64 1.32% 6.31%
Regeneron Pharmaceuticals 732.16 3.56 0.49% 11.12%
Roche Holding 288.20 0.30 0.10% -10.69%
Seattle Genetics 195.56 1.55 0.80% 45.76%
Sanofi 50.71 0.26 0.52% -4.70%
Sarepta Therapeutics 124.73 -0.09 -0.07% 71.80%
Teva Pharmaceutical Industries 2,680.00 -89.00 -3.21% -11.90%
United Therapeutics 209.58 4.39 2.14% -9.39%
Vertex Pharmaceuticals 325.39 0.09 0.03% 20.78%

Indexes Price Day Year
US500 4185 -20.18 -0.48% 2.04%
USND 12977 -40.42 -0.31% 8.19%
USNDX 14300 -55.02 -0.38% 13.96%

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals traded at $733.18 this Wednesday May 31st, increasing $4.58 or 0.63 percent since the previous trading session. Looking back, over the last four weeks, Regeneron Pharmaceuticals gained 9.12 percent. Over the last 12 months, its price rose by 11.27 percent. Looking ahead, we forecast Regeneron Pharmaceuticals to be priced at 704.17 by the end of this quarter and at 645.06 in one year, according to Trading Economics global macro models projections and analysts expectations.

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, Kevzara (sarilumab) Solution for Subcutaneous Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion.